GTx Receives clearance for New Capesaris Trials

GTx Inc. announced that FDA regulators will allow it to restart the clinical trials of its investigational prostate cancer drug Capesaris for men with castrate resistant advanced prostate cancer. They anticipate that the trials of Capesaris will begin during the third quarter of 2012. The trial is designed to evaluate Capesaris as a secondary treatment [...]

Why Are Gays Excluded From Medical Research Studies?

For a reason that I can not figure out there are a small but still significant portion of medical studies that automatically exclude gays from participating without an apparent scientific reason. These studies usually have requirements that the subject be in a “reciprocal relationship with a person of the opposite sex." Sometimes the exclusion of [...]

Mayan Prophecy

I've been thinking lately about the Mayan Prophecy (the world ending on 12/21/12). Apparently a lot of people believe that this end of days might actually be a global re-alignment in thought... whereas we have a whole world that is dominated by patriarchal masculine attitudes and behaviors, even in women, there might be a re-introduction [...]

By |2012-05-04T16:47:25-04:00May 4th, 2012|Activism|0 Comments

What Is The Actual Survival Advantage for Men Who Take Provenge? It’s Longer Than We Thought!

Understanding and deciding on appropriate treatments for men with advanced prostate cancer can be confusing. All the treatments come with side effects and one never knows what the benefits might be for an individual. Even with good clinical trials, men with advanced prostate cancer still need to navigate a most unclear path. Provenge, ever since [...]

Go to Top